Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma: A Prospective, Multicenter Phase IB/II Trial (SAKK 75/06)Thomas Ruhstaller, Viviane Hess, Walter Mingrone et al.|Journal of Clinical Oncology|2011Cited by 105
A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicityMarkus Borner, A. Roth, J. Bernhard et al.|Annals of Oncology|2005Cited by 103
Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)Francesco Zappa, Miklos Pless, C. Droege et al.|Lung Cancer|2012Cited by 32
Capecitabine with Weekly Paclitaxel for Advanced Breast Cancer: A Phase I Dose-Finding TrialCatrina Uhlmann, Stefan Aebi, Pierluigi Ballabeni et al.|Oncology|2004Cited by 16
Bevacizumab (B) and erlotinib (E) as first-line therapy in metastatic nonsquamous non-small cell lung cancer (NSCLC) followed by platinum-based chemotherapy (CT) at disease progression (PD): A multicenter phase II trial, SAKK 19/05.Francesco Zappa, Miklos Pless, S. Crowe et al.|Journal of Clinical Oncology|2011Cited by 3